As of April 16, 2025, IDEAYA Biosciences (IDYA) has a market cap of $1.49 billion USD. According to our data, IDEAYA Biosciences is ranked No.4438 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $1.49 B |
-33.08%
|
Dec 31, 2024 | $2.22 B |
-27.77%
|
Dec 29, 2023 | $3.08 B |
95.82%
|
Dec 30, 2022 | $1.57 B |
-23.14%
|
Dec 31, 2021 | $2.04 B |
68.86%
|
Dec 31, 2020 | $1.21 B |
86.67%
|
Dec 31, 2019 | $0.65 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Blueprint Medicines
BPMC
|
$5.21 B |
0.000 M
|
![]() USA
|
![]() Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
![]() USA
|
![]() Revolution Medicines
RVMD
|
$6.75 B |
0.000 M
|
![]() USA
|
![]() Relay Therapeutics
RLAY
|
$0.47 B |
-0.000 M
|
![]() USA
|
![]() Zai Lab
ZLAB
|
$3.33 B |
0.000 M
|
![]() China
|
![]() Kura Oncology
KURA
|
$0.49 B |
0.000 M
|
![]() USA
|
![]() Arcus Biosciences
RCUS
|
$0.85 B |
-0.000 M
|
![]() USA
|
![]() Iovance Biotherapeutics
IOVA
|
$1.06 B |
-0.000 M
|
![]() USA
|
![]() Fate Therapeutics
FATE
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.32 B |
0.000 M
|
![]() USA
|
![]() Adaptimmune Therapeutics
ADAP
|
$64.18 M |
-0.000 M
|
![]() UK
|
![]() G1 Therapeutics
GTHX
|
$0.38 B |
0.000 M
|
![]() USA
|
Market Cap | = | IDYA Stock Price | * | IDYA Shares Outstanding |
= | $16.98 | * | 87.54 M | |
= | $1.49 B |